2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus.

Autor: Yin, Huiqi, Li, Liming, Feng, Xiwei, Wang, Zijun, Zheng, Meiling, Zhao, Junpeng, Fan, Xinyu, Wu, Wei, Gao, Lingyu, Zhan, Yijing, Zhao, Ming, Lu, Qianjin
Zdroj: Signal Transduction & Targeted Therapy; 11/17/2024, Vol. 9 Issue 1, p1-15, 15p
Databáze: Complementary Index
Externí odkaz: